Large Molecule Bioanalysis done differently

To help you achieve more.

We are a bioanalytical lab that has evolved the model for partnership in large molecule bioanalysis to benefit our customers and the patients they serve.

Services Delivered Scientist to Scientist

Our fully integrated GxP services are driven by your assay requirements and delivered by our veteran scientists – collaboratively, accurately, and on time.

biomarkers

Biomarkers

immunogenicity

Immunogenicity

pharmacokinetics

Pharmacokinetics (PK)

cell-based-assays

Cell-Based Assays

Solutions Enabled by World-Leading Expertise

Our team is comprised of recognized experts in effectively navigating complex and evolving opportunities for biotherapeutics innovation.

biosimilars

Biosimilars

gene-therapy

Gene Therapy

antibody-drug-conjugates

Antibody Drug Conjugates (ADCs)

immuno-oncology

Immuno-oncology

platform comparison guide

webinar title
NOW ACCESSIBLE ON-DEMAND

Clinical Relevance of (Unwanted Drug-Induced) Immune Responses

Webinar Co-Hosted with Bioanalysis Zone

Methods for the detection of drug-induced antibodies have become much more sensitive, but the question remains to be answered: are antibodies at this low concentration level clinically relevant? BioAgilytix’s Global CSO, Dr. Arno Kromminga addresses this subject and more.

Download Recording

The Bioagilytix Perspective

Explore the BioAgilytix way of thinking. Visit our Resource Center to learn more about our scientists’ expertise through case studies, blogs, industry articles and other scientific resources.

resource center

Visit Resource Center

usa europe labs

Advanced bioanalytical lab facilities to support all phases of large molecule global studies.

    LinkedIn Company Updates

  • 2 Days Agoview on linkedin

    BioAgilytix

    While CAR-T cell therapy offers exciting opportunities for treating solid tumors, it also can evoke cytokine release syndrome (CRS) cytotoxicity. Learn about the panels we use to monitor various cytokine levels throughout CAR-T therapy: https://lnkd.in/ei_ef-2

  • 2 Days Agoview on linkedin

    BioAgilytix

    Interested in applying your scientific expertise to support the development of promising new large molecule drugs? Consider joining our Durham, NC team as a Scientist I, II, or III. View the qualifications and how you can apply: https://lnkd.in/ezxzjCQ

  • 5 Days Agoview on linkedin

    BioAgilytix

    At the Cambridge Healthtech Institute Immuno-Oncology Summit Europe on Monday, Dr. Arno Kromminga will lead a discussion on biomarker use in regulated bioanalysis in immuno-oncology. Make sure you mark your calendars for 18 March at 17:15 to hear his scientific perspective. https://lnkd.in/ewQHfSs

global map

Advancing Bioanalytical Excellence Internationally

Choose a Location to learn more about the premier bioanalytical services and solutions available at each of our advanced laboratories in the USA and Europe.